I agree to the Terms of Use , Privacy Notice and Cookie Notice.
Australian research could be key to combating the rising threat of antibiotic resistance and saving millions of lives.
Worth up to $2.4 billion, the acquisition is also the latest in a series of buyouts involving startups with technologies that modify immune cells inside the body.
Annika Raj, a senior at Biotechnology High School, was recently named as a recipient of the Jersey Shore YMCA Youth Changemaker Award.
Pandorum’s primary focus is on ocular surface diseases, such as Stevens–Johnson Syndrome and Neurotrophic Keratitis, for ...
Minister for Information Technology, Biotechnology and Rural Development Priyank Kharge said the state will unveil an Ocean Farming Policy, back AI–biotech convergence, and push a greener data ...
XOMA Royalty Corporation (NASDAQ: XOMA) ("XOMA Royalty" or the "Company"), a biotechnology royalty aggregator playing a distinctive role in helping ...
Generation Bio Stockholders Received $4.2913 Per Share in Cash Plus a Contingent Value RightEMERYVILLE, Calif., Feb. 09, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA) (“XOMA Royalty ...
Genentech, considered one of the biotech industry’s founding companies, announced in May 2025 that it planned to build a $700 million, 700,000-square-foot manufacturing facility in Holly Springs and ...
His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President, Prime Minister and Ruler of Dubai, today opened the World ...
In nanoscale particle research, precise control and separation have long been a bottleneck in biotechnology. Researchers at the University of Oulu have now developed a new method that improves ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results